(2018) 16:e2001959
Cuando analizamos el programa ACHIEVE, orforglipron demostr consistentemente un control superior de la y una prdida de peso, lo que nos da gran confianza en lo que puede ofrecer a los pacientes, afirm Thomas Seck , MD, vicepresidente senior de desarrollo de productos en Lilly Cardiometabolic Health
Post hoc pairwise comparisons were performed for significant interaction effects using estimated marginal means with Sidak correction to control for multiple comparisons
In contrast, GLP-1 receptor agonists improve metabolic health and may improve endogenous testosterone production without impairing spermatogenesis, Werthman explained
doi:10.1111/dom.14725 15.Wilding JPH, Batterham RL, Kandler K, Davies M, Van Gaal LF, Lingvay I